Benitec Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 20 Nov 24 | BuyUS$416,616 | Suvretta Capital Management, LLC | Company | 41,436 | US$10.22 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,457,277 | 6.28% |
| General Public | 5,152,041 | 22.2% |
| Institutions | 7,736,618 | 33.3% |
| Hedge Funds | 8,870,489 | 38.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 802.5%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,870,489 | US$87.4m | 0.47% | 3.33% | |||
| 2,682,275 | US$26.4m | 206% | 0.01% | |||
| 1,379,235 | US$13.6m | 80.5% | no data | |||
| 1,041,669 | US$10.3m | 23.8% | 1.12% | |||
| 841,395 | US$8.3m | 0% | 0.02% | |||
| 796,571 | US$7.8m | -0.01% | no data | |||
| 625,000 | US$6.2m | 0% | 0.67% | |||
| 414,849 | US$4.1m | 0% | 3.46% | |||
| 272,817 | US$2.7m | 4.76% | 0.02% | |||
| 258,267 | US$2.5m | -69.2% | 0.19% | |||
| 213,067 | US$2.1m | -0.93% | no data | |||
| 151,451 | US$1.5m | 0% | 0.11% | |||
| 116,535 | US$1.1m | 128% | 0.08% | |||
| 83,987 | US$827.3k | 31.3% | no data | |||
| 60,000 | US$591.0k | 0% | 0.02% | |||
| 52,097 | US$513.2k | 0% | no data | |||
| 39,000 | US$384.1k | 0% | 1.66% | |||
| 29,800 | US$293.5k | 0% | 0.26% | |||
| 28,238 | US$278.1k | 0.84% | no data | |||
| 25,927 | US$255.4k | 0% | no data | |||
| 24,775 | US$244.0k | -0.6% | no data | |||
| 16,828 | US$165.7k | 0% | 0.19% | |||
| 14,879 | US$146.6k | 0% | no data | |||
| 14,244 | US$140.3k | 0% | no data | |||
| 6,540 | US$64.4k | 20.3% | 0.01% |